Aprea Therapeutics, Inc. (APRE)

Other Income/Expenses (Net)

$440.88K

Quarterly · Period ending: · USD

APRE logo

APRE Other Income/Expenses (Net)

Latest reported$440.88K
APRE Quarterly Other Income/Expenses (Net) (-$207.54K → $440.88K)
High-resolution chart · PNG

APRE other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
440,876
142,495
187,463
144,978
148,903
152,922
331,246
313,247
376,872
339,579
231,675
318,335
392,584
242,613
209,486
175,476
207,057
138,182
73,495
-21,940
-253,431
520,926
-1,169,144
-83,777
-1,887,012
2,472,333
-1,092,980
968,936
675,967
932,568
219,702
-207,538
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.